Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging role of mitochondria in response to HBV infection. | J Clin Lab Anal | 2022 | 36111656 | PubTator, text mining | PubMed |
| Green Synthesis-Mediated Nanoparticles and Their Curative Character Against Post COVID-19 Skin Diseases. | Curr Pharmacol Rep | 2022 | 36105411 | PubTator, text mining | PubMed |
| Hepatocytes Deficient in Nuclear Envelope Protein Lamina-associated Polypeptide 1 are an Ideal Mammalian System to Study Intranuclear Lipid Droplets. | J Lipid Res | 2022 | 36100089 | PubTator, text mining | PubMed |
| Molecular epidemiology and genetic characterization of SARS-CoV-2 in Kuwait: A descriptive study. | Front Microbiol | 2022 | 36090111 | PubTator, text mining | PubMed |
| Colorimetric and fluorometric reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for diagnosis of SARS-CoV-2. | Funct Integr Genomics | 2022 | 36089609 | PubTator, text mining | PubMed |
| Interaction between Sars-CoV-2 structural proteins and host cellular receptors: From basic mechanisms to clinical perspectives. | Adv Protein Chem Struct Biol | 2022 | 36088078 | PubTator, text mining | PubMed |
| A novel strategy for developing vaccine candidate against Jaagsiekte sheep retrovirus from the envelope and gag proteins: an in-silico approach. | BMC Vet Res | 2022 | 36085036 | PubTator, text mining | PubMed |
| The SARS-CoV-2 envelope protein disrupts barrier function in an in vitro human blood-brain barrier model. | Front Cell Neurosci | 2022 | 36082238 | PubTator, text mining | PubMed |
| Monkeypox: Some Keys to Understand This Emerging Disease. | Animals (Basel) | 2022 | 36077910 | PubTator, text mining | PubMed |
| Direct Analysis of Mitochondrial Damage Caused by Misfolded/Destabilized Proteins. | Int J Mol Sci | 2022 | 36077279 | PubTator, text mining | PubMed |
| Detection of Higher Cycle Threshold Values in Culturable SARS-CoV-2 Omicron BA.1 Sublineage Compared with Pre-Omicron Variant Specimens - San Francisco Bay Area, California, July 2021-March 2022. | MMWR Morb Mortal Wkly Rep | 2022 | 36074732 | PubTator, text mining | PubMed |
| Long Covid: where we stand and challenges ahead. | Cell Death Differ | 2022 | 36071155 | PubTator, text mining | PubMed |
Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19. | Comput Biol Med | 2022 | 36067633 | PubTator, text mining | PubMed |
| White spot syndrome virus directly activates mTORC1 signaling to facilitate its replication via polymeric immunoglobulin receptor-mediated infection in shrimp. | PLoS Pathog | 2022 | 36067252 | PubTator, text mining | PubMed |
| Immunology to Immunotherapeutics of SARS-CoV-2: Identification of Immunogenic Epitopes for Vaccine Development. | Curr Microbiol | 2022 | 36064873 | PubTator, text mining | PubMed |
| Patent intelligence of RNA viruses: Implications for combating emerging and re-emerging RNA virus based infectious diseases. | Int J Biol Macromol | 2022 | 36058387 | PubTator, text mining | PubMed |
| Localization-Based Super-Resolution Microscopy Reveals Relationship between SARS-CoV2 Spike and Phosphatidylinositol (4,5)-bisphosphate. | Proc SPIE Int Soc Opt Eng | 2022 | 36051945 | PubTator, text mining | PubMed |
| A non-invasive ultrasensitive diagnostic approach for COVID-19 infection using salivary label-free SERS fingerprinting and artificial intelligence. | J Photochem Photobiol B | 2022 | 36049288 | PubTator, text mining | PubMed |
| Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis. | Front Immunol | 2022 | 36045680 | PubTator, text mining | PubMed |
| COVIDOA: a novel evolutionary optimization algorithm based on coronavirus disease replication lifecycle. | Neural Comput Appl | 2022 | 36043205 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=43